Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Exscientia
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
January 02, 2024
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
August 03, 2023
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
July 18, 2023
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Announces Expansion of its Technology Leadership Team
June 29, 2023
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Business and Financial Update for the Full Year 2022
March 23, 2023
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in November
November 01, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes
September 20, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in September
September 07, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Report Second Quarter 2022 Financial Results on August 17, 2022
August 10, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
June 07, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Report First Quarter 2022 Financial Results on May 25, 2022
May 18, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at the BofA Securities 2022 Healthcare Conference
May 03, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer
April 05, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Report Fourth Quarter and Year End 2021 Financial Results on March 23, 2022
March 16, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Upcoming Investor Conferences in March
February 22, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
January 19, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
January 07, 2022
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
November 23, 2021
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Business Update for Third Quarter 2021
November 17, 2021
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021
November 10, 2021
From
Exscientia
Via
Business Wire
Tickers
EXAI
Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes
October 11, 2021
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement
October 05, 2021
From
Exscientia
Via
Business Wire
Tickers
EXAI
Exscientia Enters $70M Collaboration to Develop Antiviral Therapeutics Against Coronavirus and Other Viruses With Pandemic Potential
September 08, 2021
From
Exscientia
Via
Business Wire
Bristol Myers Squibb Exercises Option to Develop Exscientia’s AI-designed, Immune-modulating Drug Candidate
August 18, 2021
From
Exscientia
Via
Business Wire
Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
August 04, 2021
From
Exscientia
Via
Business Wire
Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture
July 21, 2021
From
Exscientia
Via
Business Wire
Exscientia Accelerates COVID-19 Drug Discovery Using AI
July 08, 2021
From
Exscientia
Via
Business Wire
Exscientia Acquires Personalised Medicine AI Pioneer Allcyte
June 15, 2021
From
Exscientia
Via
Business Wire
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
May 19, 2021
From
Exscientia
Via
Business Wire
Exscientia Announces Investment of up to $525M
April 27, 2021
From
Exscientia
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.